Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development. Bourla’s remarks on the company’s first-quarter earnings call came in response to a question about what Pfizer wants to see from tariff negotiations that would push…
Shares of Tesla were flat in premarket trading Thursday after the EV maker denied a Wall Street Journal report that its…
Data center demand is not slowing down in the world’s largest market centered in northern Virginia, executives at Dominion Energy said…
Nvidia blasted Anthropic Thursday in a rare public clash over artificial intelligence policy with U.S. chip export restrictions set to take effect. “American firms should focus…
Tech is saving Hollywood — though not in the way you might think. Back in 2022, e-commerce giant and…
Shares of Tesla were flat in premarket trading Thursday after the EV maker denied a Wall Street Journal report that its…
McDonald’s reported its worst quarterly sales for the United States since the height of the pandemic in 2020, the…
Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing…
Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing…